2 results
Approved WMORecruiting
To assess the efficacy and safety of LCI699 in CD patients
Approved WMORecruiting
The primary objective of the study is to evaluate the feasibility, safety, and efficacy of point-of-care manufactured 19CP02 in subjects with relapsed/refractory B-cell non-Hodgkin lymphoma.In the phase I part of the study the main objective is to…